These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 8571330

  • 1. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity.
    Kumar R, Béguin S, Hemker HC.
    Thromb Haemost; 1995 Sep; 74(3):962-8. PubMed ID: 8571330
    [Abstract] [Full Text] [Related]

  • 2. [Procoagulant nature of fibrin].
    Béguin S.
    Bull Acad Natl Med; 1998 Sep; 182(7):1479-91; discussion 1491-2. PubMed ID: 9916342
    [Abstract] [Full Text] [Related]

  • 3. The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin.
    Kumar R, Béguin S, Hemker HC.
    Thromb Haemost; 1994 Nov; 72(5):713-21. PubMed ID: 7900079
    [Abstract] [Full Text] [Related]

  • 4. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC, Dieter JP, Strebel LC, Taylor TM, Muscolino G, Feinberg H, Le Breton GC.
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of platelets in lysis of dilute plasma clots: requirement for metabolically active platelets.
    Lockhart MS, Comp PC, Taylor FB.
    J Lab Clin Med; 1979 Aug; 94(2):285-94. PubMed ID: 458246
    [Abstract] [Full Text] [Related]

  • 11. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
    Schols SE, Feijge MA, Lancé MD, Hamulyák K, ten Cate H, Heemskerk JW, van Pampus EC.
    Transfusion; 2008 Nov; 48(11):2384-94. PubMed ID: 18673348
    [Abstract] [Full Text] [Related]

  • 12. Fibrin network structure: modification by platelets.
    Dhall TZ, Shah GA, Ferguson IA, Dhall DP.
    Thromb Haemost; 1983 Feb 28; 49(1):42-6. PubMed ID: 6845271
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
    Semeraro F, Piro D, Rossiello MR, Ammollo T, Colucci M.
    Thromb Haemost; 2007 Dec 28; 98(6):1208-14. PubMed ID: 18064315
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins.
    Bendayan P, Boccalon H, Dupouy D, Boneu B.
    Thromb Haemost; 1994 May 28; 71(5):576-80. PubMed ID: 8091383
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.
    Reed GL, Matsueda GR, Haber E.
    Thromb Haemost; 1992 Sep 07; 68(3):315-20. PubMed ID: 1279832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.